Long-term analysis of the RiBVD phase II trial reveals the unfavorable impact of TP53 mutations and hypoalbuminemia in older adults with mantle cell lymphoma; for the LYSA group
RiBVD II期试验的长期分析揭示了TP53突变和低白蛋白血症对老年套细胞淋巴瘤患者的不利影响;对于LYSA组
期刊:Haematologica
影响因子:7.9
doi:10.3324/haematol.2023.283724
Carras, Sylvain; Torroja, Alexia; Emadali, Anouk; Montaut, Emilie; Daguindau, Nicolas; Tempescul, Adrian; Moreau, Anne; Tchernonog, Emmanuelle; Schmitt, Anna; Houot, Roch; Dartigeas, Caroline; Barbieux, Sarah; Corm, Selim; Banos, Anne; Fouillet, Ludovic; Dupuis, Jehan; Macro, Margaret; Fleury, Joel; Jardin, Fabrice; Sarkozy, Clementine; Damaj, Ghandi; Feugier, Pierre; Fornecker, Luc Matthieu; Chabrot, Cecile; Dorvaux, Veronique; Bouabdallah, Krimo; Amorim, Sandy; Garidi, Reda; Voillat, Laurent; Joly, Bertrand; Morineau, Nadine; Moles, Marie Pierre; Zerazhi, Hacene; Fontan, Jean; Arkam, Yazid; Alexis, Magda; Delwail, Vincent; Vilque, Jean Pierre; Ysebaert, Loic; Burroni, Barbara; Callanan, Mary; Le Gouill, Steven; Gressin, Rémy